Mengyuan Cai

HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases

R. Shui, Wentao Yang, Shu-ling Zhou, 2023, BMC Cancer.

Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns

Ming Li, Mengyuan Cai, Xiao-Li Xu, 2024, Journal of clinical pathology.